MEDISKIN AQUA CREAM - search results

medison pharma ltd - natalizumab - תרכיז להכנת תמיסה לאינפוזיה - natalizumab 300 mg / 15 ml - natalizumab - natalizumab - tysabri is indicated as monotherapy for the treatment of patients with relapsing forms of multiple sclerosis . to delay the accumulation of physical disability and reduce the frequency of clinical exacerbations. the safety and efficacy of tysabri beyond two years are unknown. because tysabri increases the risk of progressive multifocal leukoencephalopathy (pml), an opportunistic viral infection of the brain that usually leads to death or severe disability. tysabri is generally recommended for patients who have had an inadequate response to, or are unable to tolerate, alternate multiple sclerosis therapies. safety and efficacy in patients with chronic progressive multiple sclerosis have not been studied.

ইস্রায়েল - হিব্রু - Ministry of Health

פקפנט 100

medison pharma ltd - fentanyl as citrate - ספריי לאף - fentanyl as citrate 1 mg / 1 ml - fentanyl

ইস্রায়েল - হিব্রু - Ministry of Health

פקפנט 400

medison pharma ltd - fentanyl as citrate - ספריי לאף - fentanyl as citrate 4 mg / 1 ml - fentanyl